Advanced search
Publication Cover
Current Medical Research and Opinion Volume 28, 2012 - Issue 5
Submit an article Journal homepage
429
Views
8
CrossRef citations to date
0
Altmetric
Hematology: Original Article

A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia

Ilene WeitzUniversity of Southern California – Keck School of Medicine Los Angeles, CAUSACorrespondence[email protected]
,
Miguel A. SanzHematology Service, University Hospital La Fe ValenciaSpain
,
David HenryPennsylvania Oncology Hematology Associates Radnor, PAUSA
,
Martin SchipperusHaga Teaching Hospital The HagueThe Netherlands
,
Bertrand GodeauCentre Hospitalier Universitaire, Hôpital Henri Mondor CreteilFrance
,
Kelly NorthridgeOutcomes Insights Inc. Westlake Village, CAUSA
,
Michelle GleesonOutcomes Insights Inc. Westlake Village, CAUSA
,
Mark DaneseOutcomes Insights Inc. Westlake Village, CAUSA
&
Robert DeusonAmgen Inc. Thousand Oaks, CAUSA
 show all
Pages 789-796 | Accepted 05 Apr 2012, Published online: 25 Apr 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Robert Deuson, Mark Danese, Susan D. Mathias, Marieke Schoonen & Jon Fryzek. (2012) The burden of immune thrombocytopenia in adults: Evaluation of the thrombopoietin receptor agonist romiplostim. Journal of Medical Economics 15:5, pages 956-976.
Read now

Articles from other publishers (7)

Junji Lin, Xinke Zhang, Xiaoyan Li, David Chandler, Ivy Altomare, Jeffrey S. Wasser & Karynsa Cetin. (2017) Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States. Clinical Therapeutics 39:3, pages 603-609.e1.
Crossref
M. Fernanda López, María Eva Mingot, David Valcárcel, Vicente Vicente García, Allison Perrin & Ignasi Campos Tapias. (2015) Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España. Medicina Clínica 144:9, pages 389-396.
Crossref
M. Fernanda López, María Eva Mingot, David Valcárcel, Vicente Vicente García, Allison Perrin & Ignasi Campos Tapias. (2015) Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain. Medicina Clínica (English Edition) 144:9, pages 389-396.
Crossref
Aristoteles Giagounidis, Ghulam J. Mufti, Pierre Fenaux, Mikkael A. Sekeres, Jeffrey Szer, Uwe Platzbecker, Andrea Kuendgen, Gianluca Gaidano, Wieslaw Wiktor‐Jedrzejczak, Kuolung Hu, Paul Woodard, Allen S. Yang & Hagop M. Kantarjian. (2014) Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia. Cancer 120:12, pages 1838-1846.
Crossref
L. Chiche, A. Perrin, L. Stern, L. Kutikova, S. Cohen-Nizard & F. Lefrère. (2014) Coût par patient répondeur associé au traitement du purpura thrombopénique immunologique primaire par romiplostim et rituximab chez l’adulte en France. Transfusion Clinique et Biologique 21:2, pages 85-93.
Crossref
Francesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, Jean-François Viallard, Bertrand Godeau, Ingrid Pabinger, Douglas Cines, Howard Liebman, Xuena Wang & Paul Woodard. (2013) Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials. European Journal of Haematology 91:5, pages 423-436.
Crossref
Dawn Lee, Patrick Thornton, Alexander Hirst, Lucie Kutikova, Robert Deuson & Nic Brereton. (2013) Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland. Applied Health Economics and Health Policy 11:5, pages 457-469.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.